Sedative-Anxiolytic Effects on Simulated Driving Performance

Psychomotor Impairment Clinical Trial

Official title:
Alprazolam and Simulated Driving Performance: Next Day Effects

Status Completed

Clinical Trial Summary

This study evaluates the effect of anxiety drugs taken at night on the ability to drive a car the next day. Participants will receive alprazolam, placebo, or zolpidem at night before bed or in the morning before using a driving simulator to assess impairment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Psychomotor Impairment

Clinical Trial Details

NCT number	NCT03297944
Study type	Interventional
Source	University of Kentucky
Contact
Status	Completed
Phase	Phase 4
Start date	September 15, 2017
Completion date	October 25, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03104296` - Correlation Between Cerebral Oxygenation and Neurodevelopment in VLBW Preterm Infants.	N/A
Completed	`NCT02710578` - Alcohol Effects on Driving-related Skills of Young Drivers	N/A
Completed	`NCT03106363` - Combined Alcohol and Cannabis Effects on Skills of Young Drivers	Early Phase 1
Completed	`NCT01592409` - Cannabis Effects on Driving-related Skills of Young Drivers	N/A
Recruiting	`NCT04288531` - Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region